For sponsors & CROs
Published experience and protocol interests
Explore Boeson’s obesity and metabolic research expertise in Montana and Utah, including investigator experience with weight-management, diabetes and cardiovascular-risk studies.
- Weight management and obesity
- Type 1 and type 2 diabetes
- Metabolic and cardiovascular risk
- Mental health outcomes in GLP-1 research
Historical study experience, current clinical expertise, research interests and operational site capability are different. Confirm study-specific roles, staffing and facilities before selecting a site.
Identify relevant investigators

Aubrey Remmers, MD
Family medicine & obesity medicine
Obesity-medicine expertise and a broad PI portfolio spanning weight management, diabetes, cardiovascular risk and vaccines.
- Missoula · Experienced principal investigator

Jason Andersen, DO
Psychiatry
Psychiatric investigator since 2011, with adult and pediatric research experience and an interest in the psychiatric effects of GLP-1 treatments.
- Provo · Experienced principal investigator
Review associated sites
- Missoula — published investigator experience; operational requirements need feasibility review.
- Provo — published investigator experience; operational requirements need feasibility review.
Does GLP-1 research mean a treatment is available now?
No. This page describes research experience and interests. Current study availability, eligibility and treatment assignment depend on the individual protocol.
For volunteers
Start with your preferred location to see verified RealTime listings. A research area is not a list of studies accepting applications.
Choose your location & view studies
